News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Biohit Suspends Trial Aiming At H. Pylori Eviction


2/18/2014 9:28:16 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

A clinical study launched by Biohit to examine the ability of BioAcetium to help treat Helicobacter pylori infection has not produced clear-cut results. The BioAcetium Study has been suspended until further notice, whilst Biohit prioritizes other clinical studies.

Help employers find you! Check out all the jobs and post your resume.

Read at GlobeNewswire


comments powered by Disqus
Biohit
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES